Michael P Manos

8PUBLICATIONS
120CO-AUTHORS
Gene and molecular therapyInnate immunityCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 25, 2026
Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in <i>BRAF</i>-Mutant Melanoma.

|Sep 04, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder

|Jul 22, 2025
Specific oncogene activation of the cell of origin in mucosal melanoma.

Swathy Babu, Jiajia Chen, Chloé S Baron

|Apr 11, 2025
First-in-Human Clinical Trial of Vaccination with WDVAX, a Dendritic Cell-Activating Scaffold Incorporating Autologous Tumor Cell Lysate, in Patients with Metastatic Melanoma.

F Stephen Hodi, Anita Giobbie-Hurder, Kwasi Adu-Berchie

|Nov 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.

Giuseppe Tarantino, Cora A Ricker, Annette Wang

|Sep 30, 2024
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.

Brandon M Huffman, Osama E Rahma, Kevin Tyan

Pageof 2

Frequent Collaborators

5 joint publications

Anita Giobbie-Hurder

4 joint publications

F Stephen Hodi

3 joint publications

David Liu

3 joint publications

Scott J Rodig